Express Scripts Hepatitis C drug tax

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Data pix.
(KTVI) -  There's a new drug on the market that's designed to treat Hepatitis C  but there's one catch.  The drug is extremely expensive in the U.S.  and the taxpayer is footing the bill.

Dr. Steve Miller, Chief Medical Officer at St. Louis based Express Scripts, tells us all about it.

For more information visit: sovaldi.com or express-scripts.com

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.